Growing Demand for Hemp Infused Products

Monday, February 13, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, February 13, 2017 /PRNewswire/ --

The legal cannabis market in North America

is growing rapidly due to the accelerating pace of cannabis legalization in the United States. According to a report published by Market Research Future, eight states in the United States
are already legal for recreational use of cannabis, including Alaska, Colorado, Oregon, Washington, Nevada, Massachusetts, Maine and California. According to the report, growing demand for hemp in food and baby care products is another factor that could escalate the market for industrial hemp. Naturally Splendid Enterprises Ltd. (OTC: NSPDF) (TSX-V: NSP.V), Cannabis Sativa Inc. (OTC: CBDS), CV Sciences Inc. (OTC: CVSI), Lexaria Bioscience Corporation (OTC: LXRP), Medical Marijuana Inc. (OTC: MJNA).

The report indicated that rapid legalizing and growing awareness about the medicinal properties of cannabis to boost the cannabis market. the North American market size of cannabis stood over $3.5 billion in 2015. It is expected to expand at a CAGR over 33 percent over the period of 2016 to 2021. The expanding industry of legal cannabis could provide opportunities to other business and boost economic actives.

Naturally Splendid Enterprises Ltd. (OTCQB: NSPDF) (TSX-V: NSP.V) is a multifaceted biotechnology company developing, commercializing, producing, selling, and licensing an entirely new generation of hemp-derived, high quality, nutrient-dense Omega foods, nutritional food enhancers, and related products. Together with its partners are building an expanding portfolio of patents (issued and pending) and proprietary intellectual property focused on the commercial uses of industrial hemp and cannabinoid compounds in a broad spectrum of applications.

Earlier today Naturally Splendid Enterprise announced that the, "results from the previously reported dog food study conducted by the Food and Bio-processing division of Alberta Agriculture and Forestry. Naturally Splendid received the results from the dog food study on Feb.6th, 2017. The study was conducted by Dr. Xiangfeng Meng and her team at the Food Science and Technology Centre, a branch of the Food and Bio-Processing branch at the Alberta Agriculture.

Through this study, Naturally Splendid's proprietary encapsulation process, has now been proven to protect the omegas, minerals and vitamins naturally expressed in hempseed oil through the manufacturing process. By protecting the nutritional profile of the hemp oil, Naturally Splendid is developing a competitive advantage over the current methodology and techniques for adding omega nutrition to canine food formulations.

Naturally Splendid CEO Dave Eto states, "The objective of this study was to confirm that our proprietary technology used to manufacture HempOmega™ would allow for this omega rich ingredient to be added to canine foods thus; creating a competitive advantage for Naturally Splendid over existing omega ingredients for this sector. The results from this study have confirmed that our omega formulation technology can be used to infuse canine foods."

Naturally Splendid President Mr. J. Craig Goodwin reports, "While waiting for the written report from this study, Naturally Splendid has been proactive in identifying potential clients for this unique omega ingredient in a range of canine food applications. We are already in an advanced stage of discussions with a significant North American canine food processor for inclusion into their line of canine foods as well as to collaborate on further development and applications of HempOmega™. There is also opportunity for HempOmega™ to be available as an ingredient for private labelled canine food lines as well.""

"…Naturally Splendid CEO, Dave Eto adds, "We are excited with these tests results that confirm that HempOmega™ is a viable ingredient to satisfy a demand for this type of product in the pet industry. According to Euromonitor, nearly all the pet food sales growth in the US is coming from premium products, which comprise at least half the market in North America. This "premiumization" of pet foods, which includes higher-priced pet foods in traditional formats such as dry and wet products, as well as newer, high-density, freeze-dried and dehydrated foods, are all potential applications for HempOmega™."

Cannabis Sativa Inc. (OTCQB: CBDS) develops and promotes natural cannabis products. The company has entered into an agreement to acquire a 49 percent ownership interest in a 9 acre property in Los Angeles County, California. The ownership group plans to lease the property to an industrial hemp farm operator who will conduct farming activities under the Industrial Hemp provisions of California's Adult Use Marijuana Act (Prop 64). The Company's President David Tobias stated, "We are excited to play a role in what we anticipate will be one of California's first hemp farms under Prop 64." The farm will produce organic industrial hemp derived products. It is anticipated that the farm will fill part of the Company's demand for industrial hemp based products, with California grown organic industrial hemp. Farming activities are expected to commence in January of 2017.

CV Sciences Inc. (OTCQB: CVSI) operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic cannabidiol and, a consumer product division in manufacturing, marketing and selling plant-based cannabidiol products to a range of market sectors. The company's brand, PlusCBD Oil™, is the company's top-selling brand of hemp-derived cannabidiol oil for consumers in the natural products industry. Its PurifiedLiquids™ is CV Science's newest addition to their consumer products portfolio that offers cannabidiol vape e-liquids in different flavors.

Lexaria Bioscience Corporation (OTCQB: LXRP) is a food biosciences company with a proprietary technology for improved delivery of bioactive compounds. The Company's lipophilic enhancement technology has been shown to enhance the bioavailability of orally ingested cannabinoids, while also masking taste. This technology promotes healthy ingestion methods, lower overall dosing and higher effectiveness in active molecule delivery. The Company's technology is patent-protected for cannabidiol and all other non-psychoactive cannabinoids, and patent-pending for Tetrahydrocannabinol, other psychoactive cannabinoids, non-steroidal anti-inflammatory drugs, nicotine and other molecules.

Real Scientific Hemp Oil (RSHO), a product of premier cannabis and hemp industry, Medical Marijuana Inc. (OTC: MJNA) had recently secured approval in Brazil to treat a patient with Alzheimer disease. This will further expand the medical conditions for which Brazil allows the oil to be used. According to CFN Media Group, RSHO is a full-spectrum CBD oil extracted from hemp plants grown in Northern Europe without the use of herbicides, pesticides, or chemical fertilizers, and the final product is triple lab tested at ISO/IEC 1725:2005 accredited food safety labs. Strict EU regulations ensure that the hemp oil is extremely pure prior to export, while the products pass all federal requirements for importation into the U.S. and are available in over 40 countries around the world. The Brazilian government's decision to authorize a doctor's prescription for hemp-based CBD oil for the treatment of Alzheimer's disease acknowledges its potential as a treatment.

Please SIGN UP NOW at To Receive Alerts on Trending Financial News from all these companies. "The Latest Buzz in Financial News"

Subscribe Now! Watch us report from NYSE

Follow us on Twitter for real time Financial News Updates:

Follow and talk to us on Instagram:

Facebook Like Us to receive live feeds:

About, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the "Site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and marketing firm enters into service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. has not been compensated directly by any of the companies mentioned here in this editorial. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on along with other financial news PR media services. does not offer any personal opinions as we purely incorporate public market research along with financial and corporate news. only regurgitates financial or corporate news through our unique financial newswire and media platform. expects to be compensated seven thousand for financial news dissemination and pr services from a third party non affiliate for naturally splendid enterprises ltd. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. will always disclose any compensation in securities or cash payments for financial news PR advertising. does not undertake to update any of the information on the Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on the Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit:

For further information:

Media Contact: , +1-877-601-1879




Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store